RxSight (RXST) Share-based Compensation (2020 - 2026)
RxSight's (RXST) quarterly Share-based Compensation came in at $21.4 million in Q1 2026, up 199.72% YoY from $7.1 million in Q1 2025, and up 190.04% on a QoQ basis from -$23.8 million in Q4 2025.
RxSight (RXST) Share-based Compensation (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Share-based Compensation data on file, last reported at $21.4 million in Q1 2026.
- Quarterly Share-based Compensation rose 199.72% year-over-year to $21.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.4 million (down 20.97% YoY) and the FY2025 annual result came in at $17.8 million, down 27.75% from the prior year.
- Share-based Compensation improved to $21.4 million in Q1 2026, from -$23.8 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $24.2 million in Q2 2025 to a low of -$23.8 million in Q4 2025.
- A 5-year average of $5.2 million and a median of $4.7 million in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation jumped 3687.36% — and 2025, when it tumbled 426.37%.
- Tracing RXST's Share-based Compensation over 5 years: stood at $10.3 million in 2022, then jumped by 52.69% to $15.7 million in 2023, then plunged by 53.73% to $7.3 million in 2024, then plunged by 426.37% to -$23.8 million in 2025, then soared by 190.04% to $21.4 million in 2026.
- The last three Share-based Compensation figures came in at $21.4 million (Q1 2026), -$23.8 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - | 29.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.40 Mn |
| Jun 30, 2026 | 29.40 Mn |
| Mar 31, 2026 | 21.40 Mn |
| Mar 31, 2026 | 21.40 Mn |
| Dec 31, 2025 | -23.77 Mn |
| Dec 31, 2025 | -23.77 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 24.20 Mn |
| Jun 30, 2025 | 24.20 Mn |
| Mar 31, 2025 | 7.14 Mn |
| Mar 31, 2025 | 7.14 Mn |
| Dec 31, 2024 | 7.28 Mn |
| Dec 31, 2024 | 7.28 Mn |
| Sep 30, 2024 | 6.55 Mn |
| Sep 30, 2024 | 6.55 Mn |
| Jun 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 6.11 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.70 Mn |